| abstract |
The present invention relates to compounds of the formula (I): (See Formula) or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a mixture of racemates, as well as their preparation procedure, their use in the synthesis of peptide, said peptide and the use of said peptide. |